On ECHEMI
Home > Drugs > Hainan Meimei Xilin Biopharmaceutical Co., Ltd.

Hainan Meimei Xilin Biopharmaceutical Co., Ltd.

  • Founded in:

    2007-12-24
  • Country:

    China China
  • Address:

    Factory Building No. 26, Guilinyang Development Zone, Meilan District, Haikou City
  • Tax NO.:

    91460000798744593P
  • Registered Funds:

    10 million yuan
  • Website:

  • Email:

Related Drugs
Cefmetazole Sodium for Injection
Name Description Content CAS NO. Registered Holders
Cefmetazole sodium

Unspecified

More

Unspecified

56796-39-5 14
Cefmetazole Sodium for Injection
Name Description Content CAS NO. Registered Holders
Cefmetazole sodium

Not described in detail

More

Not described in detail

56796-39-5 14
Lysine aspirin for injection
The main ingredients of this product are: Lysine
Name Description Content CAS NO. Registered Holders
DL-Lysine acetylsalicylate

Overdose of this product (equivalent to more than 5g of aspirin per day) can cause salicylic acid reaction, so the drug should be discontinued immediately and glucose injection containing sodium bicarbonate should be given intravenously to accelerate the excretion of salicylate from urine. Hemodialysis or peritoneal dialysis may be considered for severe overdose; if bleeding occurs, blood transfusion or vitamin K supplementation should be given.

More

Overdose of this product (equivalent to more than 5g of aspirin per day) can cause salicylic acid reaction, so the drug should be discontinued immediately and glucose injection containing sodium bicarbonate should be given intravenously to accelerate the excretion of salicylate from urine. Hemodialysis or peritoneal dialysis may be considered for severe overdose; if bleeding occurs, blood transfusion or vitamin K supplementation should be given.

62952-06-1 13
Lysine aspirin for injection
The main ingredients of this product are: Lysine
Name Description Content CAS NO. Registered Holders
DL-Lysine acetylsalicylate

Overdose of this product (equivalent to more than 5g of aspirin per day) can cause salicylic acid reaction, so the drug should be discontinued immediately and glucose injection containing sodium bicarbonate should be given intravenously to accelerate the excretion of salicylate from urine. Hemodialysis or peritoneal dialysis may be considered for severe overdose; if bleeding occurs, blood transfusion or vitamin K supplementation should be given.

More

Overdose of this product (equivalent to more than 5g of aspirin per day) can cause salicylic acid reaction, so the drug should be discontinued immediately and glucose injection containing sodium bicarbonate should be given intravenously to accelerate the excretion of salicylate from urine. Hemodialysis or peritoneal dialysis may be considered for severe overdose; if bleeding occurs, blood transfusion or vitamin K supplementation should be given.

62952-06-1 13
Lysine aspirin for injection
The main ingredients of this product are: Lysine
Name Description Content CAS NO. Registered Holders
DL-Lysine acetylsalicylate

Overdose of this product (equivalent to more than 5g of aspirin per day) can cause salicylic acid reaction, so the drug should be discontinued immediately and glucose injection containing sodium bicarbonate should be given intravenously to accelerate the excretion of salicylate from urine. Hemodialysis or peritoneal dialysis may be considered for severe overdose; if bleeding occurs, blood transfusion or vitamin K supplementation should be given.

More

Overdose of this product (equivalent to more than 5g of aspirin per day) can cause salicylic acid reaction, so the drug should be discontinued immediately and glucose injection containing sodium bicarbonate should be given intravenously to accelerate the excretion of salicylate from urine. Hemodialysis or peritoneal dialysis may be considered for severe overdose; if bleeding occurs, blood transfusion or vitamin K supplementation should be given.

62952-06-1 13
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.